| 000 | 01059cam a22002774a 4500 | ||
|---|---|---|---|
| 001 | vtls003218976 | ||
| 003 | MY-SjTCS | ||
| 005 | 20200226112207.0 | ||
| 008 | 110624s2010 enka 001 0 eng | ||
| 020 | _a9780521887236 (hbk.) | ||
| 020 | _a0521887232 (hbk.) | ||
| 039 | 9 |
_a201202030848 _bpushpa _c201110251726 _dmuhammad_fadzli _c201110251724 _dmuhammad_fadzli _c201109221244 _dsiew_eng _y201106240959 _zmalathy |
|
| 082 | 0 | 4 |
_a615.19 _bDRU 2010 |
| 245 | 0 | 0 |
_aDrug design : _bstructure- and ligand-based approaches / _cedited by Kenneth M. Merz, Dagmar Ringe, Charles H. Reynolds. |
| 260 |
_aCambridge : _bCambridge University Press, _c2010. |
||
| 300 |
_ax, 274 p. : _bill. (some col.) ; _c29 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aDrugs _xDesign. _921816 |
|
| 650 | 0 |
_aDrugs _xStructure-activity relationships. _945080 |
|
| 700 | 1 |
_aMerz, Kenneth M., _d1959- |
|
| 700 | 1 | _aRinge, Dagmar. | |
| 700 | 1 |
_aReynolds, Charles H., _d1957- |
|
| 920 | _aBMS : 168512 | ||
| 921 | _aSMN : 167297 | ||
| 922 | _aPHA : 178008 | ||
| 999 |
_c91263 _d91263 |
||